10-Q: Q3 2024 Earnings Report
FMR LLC Acquires New Stake in ARCA Biopharma Inc
Oruka Therapeutics Completes Merger With ARCA Biopharma, Begins Trading Under ORKA, Appoints CRISPR CEO as Chairman
Express News | Oruka Therapeutics Announces Closing of Merger With ARCA Biopharma and Previously Announced Private Placement of $275 Million
Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
ARCA Biopharma To Carry Out 1-for-12 Reverse Stock Split On September 3rd, 2024
August 29th (Eastern Time) - $ARCA biopharma(ABIO.US)$ is about to implement a 1-for-12 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from September 3rd, 2024